IDEAS home Printed from https://ideas.repec.org/a/spr/drugsa/v48y2025i5d10.1007_s40264-024-01510-9.html
   My bibliography  Save this article

Multi-Stakeholder Call to Action for the Future of Vaccine Post-Marketing Monitoring: Proceedings from the First Beyond COVID-19 Monitoring Excellence (BeCOME) Conference

Author

Listed:
  • Vincent Bauchau

    (Independent, Previously GSK, Vaccine Safety)

  • Kaatje Bollaerts

    (P95 (Epidemiology and Pharmacovigilance Consultant and Services))

  • Phil Bryan

    (GSK (Safety Evaluation and Risk Management))

  • Jim Buttery

    (Murdoch Childrens Research Institute, University of Melbourne)

  • Kourtney Davis

    (Janssen Research and Development LLC (Global Epidemiology))

  • Robert T. Chen

    (Brighton Collaboration (A Program of the Task Force for Global Health))

  • Daniel R. Feikin

    (World Health Organization)

  • Antonella Fretta

    (Pfizer (Worldwide Medical & Safety))

  • Sarah Frise

    (AstraZeneca (Global Patient Safety))

  • Sonja Gandhi-Banga

    (Sanofi (Global Pharmacovigilance))

  • Hector S. Izurieta

    (US Food and Drug Administration (Center for Biologics Evaluation and Research))

  • Corinne Jouquelet-Royer

    (Sanofi (Patient Safety and Pharmacovigilance))

  • Alena Khromava

    (Sanofi (Global Pharmacovigilance))

  • Lin Li

    (Sanofi (Epidemiology and Benefit Risk))

  • Raj Long

    (Independent, Previously Bill & Melinda Gates Foundation (Safety & Pharmacovigilance))

  • Sarah MacDonald

    (Pfizer (Worldwide Medical & Safety))

  • Lydie Marcelon

    (Sanofi (Epidemiology and Benefit Risk Evaluation))

  • Robert Massouh

    (GSK (Safety Evaluation and Risk Management))

  • Wilhelmine Meeraus

    (AstraZeneca (Medical Evidence, Vaccines & Immune Therapies))

  • Flor M. Munoz

    (Baylor College of Medicine and Texas Children’s Hospital)

  • Karen Naim

    (Pfizer (Worldwide Medical & Safety))

  • Dale Nordenberg

    (Thriive.AI)

  • Hanna Nohynek

    (National Institute for Health and Welfare (Infectious Diseases Control and Vaccines))

  • Heather Rubino

    (Pfizer (Worldwide Medical & Safety))

  • Daniel A. Salmon

    (Johns Hopkins Bloomberg)

  • Sarah Sellers

    (Novavax (Safety Science and Surveillance))

  • Laurence Serradell

    (Sanofi (Epidemiology and Benefit Risk Evaluation))

  • Laurence Torcel-Pagnon

    (Sanofi (Vaccines Medical Global Evidence Generation Influenza))

  • Jamie Wilkins

    (Pfizer (Worldwide Medical & Safety))

Abstract

No abstract is available for this item.

Suggested Citation

  • Vincent Bauchau & Kaatje Bollaerts & Phil Bryan & Jim Buttery & Kourtney Davis & Robert T. Chen & Daniel R. Feikin & Antonella Fretta & Sarah Frise & Sonja Gandhi-Banga & Hector S. Izurieta & Corinne , 2025. "Multi-Stakeholder Call to Action for the Future of Vaccine Post-Marketing Monitoring: Proceedings from the First Beyond COVID-19 Monitoring Excellence (BeCOME) Conference," Drug Safety, Springer, vol. 48(5), pages 577-585, May.
    • Handle: RePEc:spr:drugsa:v:48:y:2025:i:5:d:10.1007_s40264-024-01510-9
    DOI: 10.1007/s40264-024-01510-9
    as

    Download full text from publisher

    File URL: http://link.springer.com/10.1007/s40264-024-01510-9
    File Function: Abstract
    Download Restriction: Access to the full text of the articles in this series is restricted.
    File URL: https://libkey.io/10.1007/s40264-024-01510-9?utm_source=ideas
    LibKey link: if access is restricted and if your library uses this service, LibKey will redirect you to where you can use your library subscription to access this item
    ---><---

    As the access to this document is restricted, you may want to search for a different version of it.

    More about this item

    Statistics

    Access and download statistics

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:spr:drugsa:v:48:y:2025:i:5:d:10.1007_s40264-024-01510-9. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    We have no bibliographic references for this item. You can help adding them by using this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.springer.com/economics/journal/40264 .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.